Denmark· DK-28105600015
Zavicefta
A ceftazidim und beta-lactamase-inhibitor product containing avibactamnatrium, ceftazidim, registered in Denmark by Pfizer Ireland Pharmaceuticals. The same ATC class is registered in 10 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Ceftazidim und beta-lactamase-inhibitor is registered in 10 of 19 countries.
Countries holding a registration under ATC J01DD52 (ceftazidim und beta-lactamase-inhibitor), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 7 of them publish a price we can compare per daily dose
Ceftazidim und beta-lactamase-inhibitor · ATC J01DD52
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of ceftazidim und beta-lactamase-inhibitor costs, country by country.
Normalised to the WHO defined daily dose (6 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ceftazidim und beta-lactamase-inhibitor · price per daily dose (6 g)
USD · FX 28 Sept 2026
- CH Switzerland$407.92
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Avibactamnatrium, CEFTAZIDIM
- Manufacturer
- Pfizer Ireland Pharmaceuticals
- Country
- Denmark (DK)
- ATC code
- J01DD52
- ATC class
- Ceftazidim und Beta-Lactamase-Inhibitor
- Defined daily dose
- 6 g, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28105600015
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J01DD52
Ceftazidim und beta-lactamase-inhibitor, as other registers publish it.
- NorwayZaviceftaPfizer Ireland Pharmaceuticals Unlimited Company
- IcelandZaviceftaPfizer Ireland Pharmaceuticals
- FinlandZaviceftaOrifarm Oy
- PolandZaviceftaPfizer Ireland Pharmaceuticals
- FinlandZaviceftaPfizer Ireland Pharmaceuticals Unlimited Company
- CzechiaZAVICEFTAPfizer Ireland Pharmaceuticals Unlimited Company, Ringaskiddy
- BelgiumZavicefta 2 g - 0.5 gPfizer Ireland Pharmaceuticals Unlimited Company
- NetherlandsZAVICEFTA 2 g/0,5 g, poeder voor concentraat voor oplossing voor infusiePfizer Ireland Pharmaceuticals, Operations Services Group
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/863a4bcc-a283-45b1-9677-18cd6f8998a8 GET /v1/drugs/863a4bcc-a283-45b1-9677-18cd6f8998a8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "2000mg+500mg",
"auth_role": "MOD",
"dk_drugid": "28105600015",
"substance": "Avibactamnatrium, CEFTAZIDIM",
"auth_procedure": "Central",
"in_medicinpriser": true,
"registration_date_serial": "42545"
}See everything about ceftazidim und beta-lactamase-inhibitor.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.